Nuveen, LLC Keros Therapeutics, Inc. Call Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
168Shares Held
37.8MCall Options Held
646KPut Options Held
670K-
Jpmorgan Chase & CO New York, NY2.6MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$37.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$27.6 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$24.6 Million2.53% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $375M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...